Alexander M. Porte, Ph.D.

Patent Agent
New York

Alexander Porte is a registered patent agent and is a member of the Patent Group’s Life Sciences team. His practice focuses on various aspects of patent prosecution, due diligence, and freedom to operate analysis, working primarily with clients in the life sciences. He has also worked on intellectual property litigation, including technical support for Hatch-Waxman litigation.

Prior to his role as a patent agent in the legal industry, Alexander served as a Principal Scientist at Pfizer. He has more than 20 years of pharmaceutical research experience in both medicinal and synthetic chemistry.

Professional Highlights

Publications

Co-author, "Discovery of Cytotoxic Dolastatin 10 Analogues with N-Terminal Modifications," Journal of Medicinal Chemistry, 2014

Co-author, “Recent Advances in the Identification of γ-Secretase Inhibitors to Clinically Test the Αβ Oligomer Hypothesis of Alzheimer’s Disease,” Journal of Medicinal Chemistry, 2009

Co-author, “Discovery of Begacestat, a Notch-1-Sparing γ -Secretase Inhibitor for the Treatment of Alzheimer's Disease,” Journal of Medicinal Chemistry, 2008

Credentials 

Education

Texas A&M University (Ph.D., organic chemistry, 1998)

Calvin College (B.S., chemistry, 1992)

Admissions

U.S. Patent and Trademark Office